Hillsdale Investment Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$175K Buy
118,100
+2,000
+2% +$2.96K 0.01% 466
2025
Q1
$297K Buy
+116,100
New +$297K 0.02% 393